Abbott Laboratories

vorige Seite Seite 1 von 7 nächste Seite

Abbott und Cristiano Ronaldo arbeiten zusammen, um junge Menschen zum Blut spenden anzuregen

Blut ist DER Saft des Lebens, doch vielen Menschen wird dies erst bewusst, wenn die Lage kritisch ist.

OTS0001
22.10.2015 01:55
 

Abbotts wegweisende Plattform für die Diagnostik von Infektionskrankheiten, IRIDICA, jetzt auch in Europa

Abbott kündigte heute an, dass seine innovative Diagnoseplattform IRIDICA jetzt in Europa und anderen Staaten mit CE-Kennzeichnung zugänglich ist.

OTS0024
11.12.2014 09:02
 

Abbott to Separate into Two Leading Companies in Diversified Medical Products and Research-Based Pharmaceuticals

Today Abbott announced that it plans to separate into two publicly traded companies, one in diversified medical products and the other in research-based pharmaceuticals.

OTE0012
19.10.2011 15:01
 

Abbott Confirms Long-Term Commitment to HIV Care with the Planned Development of New Formulations

Abbott announced today that it plans to develop two new formulations of its HIV medicines, Kaletra (lopinavir/ritonavir) and Norvir (ritonavir), to offer new formulation options for people living with …

OTE0005
15.07.2011 15:17
 

Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech

- Abbott and Facet Biotech Corporation announced today a definitive agreement for Abbott to acquire Facet, enhancing Abbott's early- and mid-stage pharmaceutical pipeline.

OTE0006
09.03.2010 22:56
 

Twenty-Five Years of HIV Blood Testing Helped to Positively Transform Global Health Crisis

Imagine delaying a life-saving surgery or being afraid to receive or donate blood for fear of contracting HIV (http://www.who.int/hiv/en/).

OTE0004
02.03.2010 13:33
 

Abbott Completes Acquisition of Solvay Pharmaceuticals

Abbott today announced that it has completed its EUR 4.5 billion (US$6.2 billion) acquisition of Belgium-based Solvay Pharmaceuticals, providing Abbott with a large and complementary portfolio of …

OTE0002
16.02.2010 07:32
 

Abbott to Suspend Marketing of Obesity Medicine Sibutramine in European Union Countries

Today the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) voted to recommend the suspension of marketing authorizations for all anti-obesity medicines containing …

OTE0003
21.01.2010 21:57
 

Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test

A new diagnostic tool, which studies show can aid in determining the risk of whether a pelvic mass is benign or malignant, is now available in Europe.

OTE0005
14.01.2010 15:33
 

New Abbott Gene-Based Test for Colorectal Cancer Receives CE Mark

Abbott announced today it has received CE Marking (Conformite Europeene) in the European Union for a new molecular diagnostic test, Abbott RealTime mS9 Colorectal Cancer, a non-invasive DNA assay that …

OTE0002
06.01.2010 20:29
 

Abbott Announces Positive Three-Year Data on Its Fully Bioabsorbable Stent Technology, Initiates Large-Scale International Trial

- New ABSORB EXTEND Trial to Study Performance of Revolutionary Bioabsorbable Device in Approximately 1,000 Patients

OTE0008
16.11.2009 21:08
 

Abbott to Acquire Solvay Pharmaceuticals Business

- Diversifies Abbott's pharmaceutical products, expanding international growth platform

OTE0001
28.09.2009 07:52
 

Results from Abbott's PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease

Abbott (NYSE: ABT) today announced primary results from its groundbreaking PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) clinical trial.

OTE0007
24.09.2009 21:32
 
OTE0005
23.09.2009 23:17
 
OTE0004
23.09.2009 20:17
 
vorige Seite nächste Seite